Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
39
Number of overlapping holdings
11.3%
% of FHLC's 369 holdings also in XPH
92.9%
% of XPH's 42 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.1% | 3.3% | 3.3% |
|
MERCK & CO. INC. | 5.0% | 3.3% | 3.3% |
|
ELI LILLY & CO | 10.2% | 3.2% | 3.2% |
|
PFIZER INC | 2.7% | 3.3% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% | 4.3% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XPH
|
UNITEDHEALTH GROUP INC | 8.3% |
|
ELI LILLY & CO | 7.0% |
|
ABBVIE INC | 5.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
AMGEN INC | 2.8% |
|
JOHNSON & JOHNSON | 2.7% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
FHLC Underweight Relative to XPH
|
CORCEPT THERAPEUTICS INC | -5.4% |
 |
JAZZ PHARMACEUTICALS PLC | -4.2% |
|
INTRA-CELLULAR THERAPIES INC | -4.1% |
|
VIATRIS, INC. | -3.9% |
|
CATALENT INC | -3.8% |
|
PERRIGO CO | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.2% |
|
EDGEWISE THERAPEUTICS, INC. | -3.1% |